Iron for proliferation of cell lines and hematopoietic progenitors: Nailing down the intracellular functional iron concentration.

[1]  A. Verma,et al.  Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome. , 2014, Blood.

[2]  Amy E. Palmer,et al.  Fluorescent Sensors for Measuring Metal Ions in Living Systems , 2014, Chemical reviews.

[3]  G. Rodgers,et al.  Diagnosis and treatment of cancer‐related anemia , 2014, American journal of hematology.

[4]  N. DiBella,et al.  Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry. , 2014, Leukemia research.

[5]  I. Moura,et al.  Deferasirox and Vitamin D Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia after Demethylating Agents Failure , 2013, PloS one.

[6]  P. Subramanian,et al.  Each Member of the Poly-r(C)-binding Protein 1 (PCBP) Family Exhibits Iron Chaperone Activity toward Ferritin* , 2013, The Journal of Biological Chemistry.

[7]  F. Torti,et al.  Iron and cancer: more ore to be mined , 2013, Nature Reviews Cancer.

[8]  Xiaole Kong,et al.  Iron speciation in the cytosol: an overview. , 2013, Dalton transactions.

[9]  D. Richardson,et al.  Novel chelators for cancer treatment: where are we now? , 2013, Antioxidants & redox signaling.

[10]  Xiaole Kong,et al.  Iron: effect of overload and deficiency. , 2013, Metal ions in life sciences.

[11]  L. Vickars,et al.  Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis. , 2012, Leukemia research.

[12]  Alexandre Donzé,et al.  A Model of the Cellular Iron Homeostasis Network Using Semi-Formal Methods for Parameter Space Exploration , 2012, HSB.

[13]  J. Melo,et al.  Intracellular Retention of ABL Kinase Inhibitors Determines Commitment to Apoptosis in CML Cells , 2012, PloS one.

[14]  C. Mitsiades,et al.  Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. , 2012, Blood.

[15]  Ezequiel Bernabeu,et al.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer. , 2012, Biochimica et biophysica acta.

[16]  S. Rivella,et al.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. , 2011, Blood.

[17]  J. Stubbe,et al.  Class I ribonucleotide reductases: metallocofactor assembly and repair in vitro and in vivo. , 2011, Annual review of biochemistry.

[18]  W. Maret.  Metals on the move: zinc ions in cellular regulation and in the coordination dynamics of zinc proteins , 2011, BioMetals.

[19]  Philippe Dessen,et al.  Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia , 2010, The Journal of experimental medicine.

[20]  E. McLean,et al.  Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005 , 2009, Public Health Nutrition.

[21]  T. Stemmler,et al.  A Cytosolic Iron Chaperone That Delivers Iron to Ferritin , 2008, Science.

[22]  Leonard I. Zon,et al.  Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal , 2008, Nature.

[23]  C. Bougault,et al.  Human iron regulatory protein 2 is easily cleaved in its specific domain: consequences for the haem binding properties of the protein. , 2007, The Biochemical journal.

[24]  J. Moulis,et al.  Zinc and cadmium specifically interfere with RNA-binding activity of human iron regulatory protein 1. , 2004, Journal of inorganic biochemistry.

[25]  Or Kakhlon,et al.  The labile iron pool: characterization, measurement, and participation in cellular processes(1). , 2002, Free radical biology & medicine.

[26]  D. Richardson,et al.  The role of iron in cell cycle progression and the proliferation of neoplastic cells. , 2002, Biochimica et biophysica acta.

[27]  F. Petrat,et al.  The Chelatable Iron Pool in Living Cells: A Methodically Defined Quantity , 2002, Biological chemistry.

[28]  C. Lok,et al.  The transferrin receptor: role in health and disease. , 1999, The international journal of biochemistry & cell biology.

[29]  M. Hentze,et al.  Human Cytoplasmic Aconitase (Iron Regulatory Protein 1) Is Converted into Its [3Fe-4S] Form by Hydrogen Peroxide in Vitro but Is Not Activated for Iron-responsive Element Binding* , 1999, The Journal of Biological Chemistry.

[30]  Lesley J. Murray,et al.  Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division. , 1999, Experimental hematology.

[31]  C. Thompson.  Thrombopoietin , 1994, The Lancet.

[32]  M. Hentze,et al.  Binding of a cytosolic protein to the iron-responsive element of human ferritin messenger RNA. , 1988, Science.

[33]  H. Munro,et al.  Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5' untranslated region of ferritin heavy- and light-subunit mRNAs. , 1988, Proceedings of the National Academy of Sciences of the United States of America.